“It is now time that performance-based payments start flowing to REDD+ actors on the ground, in DRC and other countries”: World Bank response to Rainforest Foundation UK and US

Last week, Rainforest Foundation UK and US wrote to staff at the World Bank, asking the World Bank not to approve the Mai Ndombe integrated REDD programme in the Democratic Republic of Congo, because of the risks involved for local communities. Yesterday Laurent Valiergue, Senior Forestry Sepcialist at the World Bank, replied. His response is available in full below.

Continue reading

Opening up 4.6 million hectares to mining in Brazil is the “biggest attack on the Amazon of the last 50 years”. So why do Norway and Germany still describe REDD in Brazil as a “success”?

“Norway remains a proud partner to Brazil on reducing deforestation, and considers this partnership a great success.”

“Around half of Brazil’s greenhouse gas emissions are caused by changes in land use and deforestation. In order to reduce global emissions, the UN climate finance model REDD+ was developed. The Brazilian Amazon Fund is considered a successful example of how this model can be implemented.”

Continue reading

Mai Ndombe REDD programme in DRC poses serious risks to people living in the province – Rainforest Foundation UK and US letter to the World Bank

Tomorrow (28 August 2017), a meeting is planned at the World Bank. On the agenda is whether to give internal approval for the Mai Ndombe integrated REDD programme in the Democratic Republic of Congo. Ahead of the meeting, Rainforest Foundation UK and US have written to the Bank asking that the programme not be approved.

Continue reading

Thorn Medical: “The company is not in a position to meet its financial obligations and therefore must be wound up”

Thorn Medical has written to shareholders to tell them that the company is insolvent and will be placed in voluntary liquidation.

Thorn Medical is a healthcare company, founded in July 2014 by Jack Kaye. In 2015, the company announced that it was planning a £350 million listing on the London Stock Exchange. A listing on the USA’s Nasdaq was also planned. In early 2016, the company appointed Sir Eric Peacock, Sir John Lucas-Tooth, and Lord Beaverbrook to its board.

Continue reading